Thrombosis Research
Volume 126, Issue 3 , Page 163 , September 2010

The devastating consequences of thrombosis of systemico pulmonary shunts and the blind administration of aspirin

  • Yves d'Udekem

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +61 3 9345 5200 (business), +61 3 9696 1468 (home); fax: +61 3 9345 6386.

Received 9 June 2010 ,Revised 18 June 2010 ,Accepted 18 June 2010.

References 

  1. Li JS, Yow E, Berezny KY, Rhodes JF, Bokesch PM, Charpie JR, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?. Circulation. 2007;116(3):293–297
  2. Al Jubair KA, Al Fagih MR, Al Jarallah AS, Al Yousef S, Ali Khan MA, Ashmeg A, et al. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young. 1998;8(4):486–490
  3. Centazzo S, Montigny M, Davignon A, Chartrand C, Fournier A, Marchand T. Use of acetylsalicylic acid to improve patency of subclavian to pulmonary artery Gore-Tex shunts. Can J Cardiol. 1993;9(3):243–246
  4. Motz R, Wessel A, Ruschewski W, Bürsch J. Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving aspirin. Cardiol Young. 1999;9(5):474–477
  5. de Leval MR, McKay R, Jones M, Stark J, Macartney FJ. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg. 1981;81(1):112–119
  6. Cholette JM, Mamikonian L, Alfieris GM, Blumberg N, Lerner NB. Aspirin resistance following pediatric cardiac surgery. Thromb Res. 2010;126:190–196

PII: S0049-3848(10)00356-7

doi: 10.1016/j.thromres.2010.06.016

Thrombosis Research
Volume 126, Issue 3 , Page 163 , September 2010

Article Tools